These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 36540936

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Kinsenoside prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis by regulating classical NF-κB pathways.
    Hsiao HB, Lin H, Wu JB, Lin WC.
    Osteoporos Int; 2013 May; 24(5):1663-76. PubMed ID: 23143538
    [Abstract] [Full Text] [Related]

  • 43. Melatonin Inhibits Osteoclastogenesis and Bone Loss in Ovariectomized Mice by Regulating PRMT1-Mediated Signaling.
    Choi JH, Jang AR, Park MJ, Kim DI, Park JH.
    Endocrinology; 2021 Jun 01; 162(6):. PubMed ID: 33713122
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss.
    Shen G, Ren H, Shang Q, Zhang Z, Zhao W, Yu X, Tang J, Yang Z, Liang D, Jiang X.
    Theranostics; 2020 Jun 01; 10(10):4334-4348. PubMed ID: 32292498
    [Abstract] [Full Text] [Related]

  • 47. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
    Jin G, Wang FF, Li T, Jia DD, Shen Y, Xu HC.
    Med Sci Monit; 2018 Apr 26; 24():2569-2577. PubMed ID: 29698379
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Onc201 reduces osteoclastogenesis and prevents ovariectomy-induced bone loss via inhibiting RANKL-induced NFATc1 activation and the integrin signaling pathway.
    Wu L, Liang J, Li J, Xu Y, Chen J, Su Y, Xian Y, Wei J, Xu J, Zhao J, Liu Q, Yang Y.
    Eur J Pharmacol; 2022 May 15; 923():174908. PubMed ID: 35405113
    [Abstract] [Full Text] [Related]

  • 51. Effect of Menaquinone-4 on Receptor Activator of Nuclear Factor κB Ligand-Induced Osteoclast Differentiation and Ovariectomy-Induced Bone Loss.
    Lee AS, Sung MJ, Son SJ, Han AR, Hong SM, Lee SH.
    J Med Food; 2023 Feb 15; 26(2):128-134. PubMed ID: 36724309
    [Abstract] [Full Text] [Related]

  • 52. Glycyrrhizin improves bone metabolism in ovariectomized mice via inactivating NF-κB signaling.
    Tang Y, Lv XL, Bao YZ, Wang JR.
    Climacteric; 2021 Jun 15; 24(3):253-260. PubMed ID: 33084419
    [Abstract] [Full Text] [Related]

  • 53. Yukmijihwang-Tang Suppresses Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Mediated Bone Loss.
    Han SY, Kim YK.
    Molecules; 2021 Dec 14; 26(24):. PubMed ID: 34946658
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. HOTAIRM1 promotes osteogenic differentiation and alleviates osteoclast differentiation by inactivating the NF-κB pathway.
    Ren Y, Zhang K, Wang J, Meng X, Du X, Shi Z, Xue Y, Hong W.
    Acta Biochim Biophys Sin (Shanghai); 2021 Feb 04; 53(2):201-211. PubMed ID: 33404645
    [Abstract] [Full Text] [Related]

  • 56. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.
    Kim JM, Lee JH, Lee GS, Noh EM, Song HK, Gu DR, Kim SC, Lee SH, Kwon KB, Lee YR.
    BMC Complement Altern Med; 2017 Mar 23; 17(1):164. PubMed ID: 28335757
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Activating transcriptional coactivator with PDZ-binding motif by (R)-PFI-2 attenuates osteoclastogenesis and prevents ovariectomized-induced osteoporosis.
    Xu R, Liu X, Zhang Y, Wang K, Chen Z, Zheng J, Zhang T, Tong P, Qian Y, Yang W.
    Biochem Pharmacol; 2024 Jan 23; 219():115964. PubMed ID: 38049011
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.